HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Chen Selected Research

Obesity

5/2020DR10601, a novel recombinant long-acting dual glucagon-like peptide-1 and glucagon receptor agonist for the treatment of obesity and type 2 diabetes mellitus.
1/2018IRX3 is a genetic modifier for birth weight, adolescent obesity and transaminase metabolism.
4/2016Metformin prescription patterns among US adolescents aged 10-19 years: 2009-2013.
5/2015Increased Risk of Bacterial Infections among the Obese with Chronic Diseases.
1/2015Exercise training prevents the attenuation of anesthetic pre-conditioning-mediated cardioprotection in diet-induced obese rats.
2/2013Myostatin induces mitochondrial metabolic alteration and typical apoptosis in cancer cells.
9/2012Glucocorticoid receptor density correlates with health risk factors and insulin resistance in Caucasian and African American subjects.
8/2007Association analysis of vitamin D-binding protein gene polymorphisms with variations of obesity-related traits in Caucasian nuclear families.
6/2007Hospital admissions associated with body mass index in Canadian adults.
4/2006Agouti-related protein promoter variant associated with leanness and decreased risk for diabetes in West Africans.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Chen Research Topics

Disease

277Neoplasms (Cancer)
12/2023 - 01/2000
72Infections
02/2024 - 01/2000
62Inflammation (Inflammations)
04/2024 - 01/2000
37Breast Neoplasms (Breast Cancer)
05/2023 - 05/2000
32Neoplasm Metastasis (Metastasis)
11/2023 - 01/2000
32Carcinoma (Carcinomatosis)
01/2020 - 02/2000
27Hepatocellular Carcinoma (Hepatoma)
11/2023 - 02/2000
27Lung Neoplasms (Lung Cancer)
08/2022 - 01/2000
26Carcinogenesis
07/2023 - 08/2001
25Pain (Aches)
04/2024 - 01/2000
25Hypoxia (Hypoxemia)
11/2023 - 01/2001
24Fibrosis (Cirrhosis)
10/2023 - 01/2000
24Prostatic Neoplasms (Prostate Cancer)
01/2021 - 06/2000
23Necrosis
04/2024 - 06/2000
22Wounds and Injuries (Trauma)
04/2024 - 04/2000
22Type 2 Diabetes Mellitus (MODY)
01/2021 - 03/2000
20Stroke (Strokes)
08/2022 - 02/2000
19Colorectal Neoplasms (Colorectal Cancer)
10/2023 - 08/2000
18Body Weight (Weight, Body)
10/2023 - 08/2000
18Hemorrhage
05/2023 - 06/2000
18Asthma (Bronchial Asthma)
02/2022 - 07/2000
16Hypertension (High Blood Pressure)
11/2021 - 11/2000
15Melanoma (Melanoma, Malignant)
11/2023 - 03/2000
15Ischemia
04/2021 - 06/2000
15Alzheimer Disease (Alzheimer's Disease)
01/2021 - 12/2000
14Sepsis (Septicemia)
03/2024 - 02/2001
14Burns
01/2021 - 04/2000
14Leukemia
02/2018 - 01/2000
13Thrombosis (Thrombus)
12/2023 - 03/2000
13Myocardial Infarction
04/2023 - 04/2001
13Stomach Neoplasms (Stomach Cancer)
06/2022 - 10/2000
13Atherosclerosis
11/2021 - 01/2000
13Mitochondrial Diseases (Mitochondrial Disease)
10/2020 - 02/2001
13Obesity
05/2020 - 09/2000
11COVID-19
11/2023 - 04/2020
11Heart Failure
12/2022 - 06/2000
11Hypersensitivity (Allergy)
02/2022 - 01/2001
11Nasopharyngeal Carcinoma
12/2021 - 07/2001
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 06/2000
10Cardiovascular Diseases (Cardiovascular Disease)
10/2023 - 03/2010
10Ovarian Neoplasms (Ovarian Cancer)
08/2022 - 09/2010
10Proteinuria
10/2021 - 03/2001
10Adenocarcinoma
08/2021 - 06/2000
10Lymphoma (Lymphomas)
01/2021 - 03/2001
10Insulin Resistance
01/2020 - 03/2000
9Liver Diseases (Liver Disease)
06/2023 - 05/2001
9Chronic Obstructive Pulmonary Disease (COPD)
02/2023 - 08/2000

Drug/Important Bio-Agent (IBA)

123Proteins (Proteins, Gene)FDA Link
11/2023 - 01/2000
51Messenger RNA (mRNA)IBA
07/2023 - 01/2000
46CytokinesIBA
07/2023 - 01/2000
33DNA (Deoxyribonucleic Acid)IBA
12/2021 - 02/2000
25Biomarkers (Surrogate Marker)IBA
11/2023 - 04/2000
23Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2023 - 04/2000
21Therapeutic UsesIBA
10/2023 - 01/2000
20Long Noncoding RNAIBA
01/2024 - 01/2016
19VaccinesIBA
08/2023 - 11/2000
18AntigensIBA
03/2023 - 01/2000
18RNA (Ribonucleic Acid)IBA
02/2023 - 02/2001
18MicroRNAs (MicroRNA)IBA
01/2023 - 07/2007
18Peptides (Polypeptides)IBA
04/2022 - 01/2001
18EnzymesIBA
07/2021 - 07/2000
17CholesterolIBA
07/2020 - 09/2000
15CreatinineIBA
03/2024 - 06/2000
15LipidsIBA
10/2023 - 03/2000
15Glucose (Dextrose)FDA LinkGeneric
10/2023 - 09/2000
15AntibodiesIBA
06/2021 - 03/2000
15Small Interfering RNA (siRNA)IBA
09/2019 - 12/2006
15Complementary DNA (cDNA)IBA
01/2016 - 02/2000
14Oxygen (Dioxygen)IBA
02/2024 - 01/2001
14Blood Glucose (Blood Sugar)IBA
10/2023 - 08/2000
14Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 01/2003
14Anti-Bacterial Agents (Antibiotics)IBA
10/2022 - 11/2000
14Transcription Factors (Transcription Factor)IBA
06/2022 - 06/2000
14Phosphotransferases (Kinase)IBA
02/2022 - 06/2006
14Interleukin-6 (Interleukin 6)IBA
12/2021 - 03/2001
13Cisplatin (Platino)FDA LinkGeneric
01/2022 - 08/2000
12NF-kappa B (NF-kB)IBA
04/2024 - 01/2000
12CollagenIBA
06/2023 - 08/2000
11Caspase 3 (Caspase-3)IBA
01/2024 - 04/2010
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2023 - 07/2001
11salicylhydroxamic acid (SHAM)IBA
12/2022 - 04/2000
11LigandsIBA
01/2021 - 04/2000
11Insulin (Novolin)FDA Link
01/2020 - 03/2000
10InterleukinsIBA
10/2023 - 04/2010
10Retinaldehyde (Retinal)IBA
01/2023 - 09/2000
10IronIBA
01/2023 - 05/2000
10Hormones (Hormone)IBA
12/2022 - 06/2001
10Paclitaxel (Taxol)FDA LinkGeneric
12/2021 - 01/2001
10Adenosine Triphosphate (ATP)IBA
10/2020 - 06/2000
10AcidsIBA
11/2018 - 07/2000
9Apolipoproteins E (ApoE)IBA
01/2024 - 05/2000
9LipopolysaccharidesIBA
12/2023 - 05/2001

Therapy/Procedure

112Therapeutics
01/2024 - 01/2000
41Drug Therapy (Chemotherapy)
12/2023 - 01/2000
24Transplantation
02/2024 - 09/2004
21Aftercare (After-Treatment)
10/2023 - 04/2000
21Radiotherapy
01/2020 - 01/2000
19Hematopoietic Stem Cell Transplantation
02/2024 - 08/2005
13Immunotherapy
11/2023 - 07/2000
10Length of Stay
12/2023 - 06/2007